Skip to content

Alberta's Health Reforms Spark Fears for Canada's Public Medicare Future

Doctors could soon charge patients twice—once through taxes, once out of pocket. Will Alberta's reforms unravel Canada's cherished public health care?

The image shows a poster with a logo and text that reads "President Biden Capped Insulin Costs at...
The image shows a poster with a logo and text that reads "President Biden Capped Insulin Costs at $35 a Month for Seniors on Medicare Through the Inflation Reduction Act".

Alberta's Health Reforms Spark Fears for Canada's Public Medicare Future

Alberta's latest health reforms are raising concerns about the future of Canada's public medicare system. New legislation allows doctors to charge patients privately for services already covered under the Canada Health Act. At the same time, trade agreements and foreign investment rules could open the door for international firms to enter the country's health sector in unprecedented ways. Bill 11, introduced by Alberta Premier Danielle Smith, permits dual physician practice. Under the new rules, doctors can bill the public insurance plan while also charging patients directly for the same services. The law also creates space for a private insurance market covering basic health care—something long restricted under Canada's single-payer system.

Smith has suggested the province may lease health facilities to third-party operators, including foreign corporations. This shift blurs the boundary between public and private care, making it harder to limit the influence of overseas firms. Alberta's reforms come as Canada remains bound by over 100 trade and investment treaties guaranteeing foreign companies broad market access and equal treatment in domestic sectors. The CUSMA (USMCA) trade deal, while excluding investor-state dispute settlement, still leaves openings for foreign health providers. These firms could win contracts to deliver publicly funded services, further embedding private interests in provincial systems. Meanwhile, the Trump administration has previously signalled it may push Canada to weaken drug pricing controls during CUSMA's next review, potentially raising public health costs. Critics argue these changes clash with medicare's core principles. Trade agreements prioritise market access and competition, while Canada's health system relies on public funding and universal coverage. Without strict safeguards, foreign corporations could gain a stronger foothold in areas like blood clinics, labs, or even hospital operations.

Alberta's reforms and existing trade rules create new pathways for private and foreign involvement in Canadian health care. If more provinces follow suit, the balance between public and private delivery could shift further. The outcome may depend on how future trade negotiations and provincial policies address these overlapping pressures.

Read also:

Latest